Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Molecular Diagnosis of Lymphogranuloma Venereum: PCR-Based Restriction Fragment Length Polymorphism and Real-Time PCR

Servaas A. Morré, Joke Spaargaren, Johan S. A. Fennema, Henry J. C. de Vries
Servaas A. Morré
VU University Medical Center Faculty of Medicine Laboratory of Immunogenetics Section Immunogenetics of Infectious Diseases Van der Boechorststraat 7 1081 BT, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: samorretravel@yahoo.co.uk
Joke Spaargaren
Municipal Health Service Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan S. A. Fennema
Municipal Health Service Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry J. C. de Vries
Academic Medical Center Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.43.10.5412-5413.2005
  • Article
  • Info & Metrics
  • PDF
Loading

We read with interest the paper from Sturm and colleagues in which they showed a PCR-based restriction fragment length polymorphism (RFLP) to differentiate the lymphogranuloma venereum (LGV) biovars from the trachoma and urogenital biovars (6). Recently an outbreak of rectal LGV infections among men having sex with men (MSM) was reported with both symptomatic and asymptomatic patients (5). Interesting from a clinical perspective is that the LGV-based genital ulcer disease (GUD) described by Sturm is not associated with human immunodeficiency virus (HIV), while the recent outbreak of rectal LGV infections in MSM is strongly associated with HIV seropositivity. Since current commercially available diagnostics do not offer the option of distinguishing the LGV biovars from the other biovars and the current ompA PCR-based RFLP analysis for specifically identifying all individual serovars is too time consuming (1, 2), we developed a real-time PCR for rapid and easy diagnosis of LGV infections which was used for clinical and case finding purposes in this outbreak among MSM (3). We used the polymorphic membrane protein H gene (pmp gene) as a PCR target because it has a unique gap in all LGV strains of Chlamydia trachomatis, compared to other serovars, which makes the PCR highly specific. The following primers and probes were selected: LGV-F (5′ CTG TGC CAA CCT CAT CAT CAA 3′), LGV-R (5′ AGA CCC TTT CCG AGC ATC ACT 3′), and LGV MGB-probe (6-FAM-CCT GCT CCA ACA GT). Reaction details are described elsewhere (3). This assay will be much easier than the CrP-PCR-D test followed by AccI restriction as reported by Sturm for the diagnosis of LGV-based GUD in South Africa. However, we realize that real-time PCR (TaqMan, LightCycler, or Rotorgene) is not readily available everywhere; therefore, we report here a simple adaptation of our real-time PCR, resulting in a potentially easier assay than the CrP-PCR-D. When only the PCR is performed using the above-described LGV-F and LGV-R primers (so without using the probe), a PCR product of 98 bp will be generated in the case of all serovars in the trachoma biovar (serovars D to K), while the presence of serovars in the LGV biovar (serovars L1, L2, L2a, and L3) will result in a fragment of 62 bp (98 − 36 bp). In this way no restriction is needed anymore, and the PCR product can be directly analyzed at the gel level. Since the fragment is also shorter than the CrP-PCR-D fragment of 552 bp, potentially better amplification will be accomplished and fewer adverse effects of inhibition or problems with DNA quality will be encountered.

Lastly, in contrast to Sturm and colleagues, we do not think that current textbooks are incomplete in the description of the clinical picture of LGV. Early symptoms with inconspicuous ulcers without inguinal buboes have been described before (4). It is probably due only to the recent advancements in diagnostic tests for LGV, as described, e.g., by Sturm and our group, that LGV cases can now be better detected during these early stages of the infection.

  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Lister, N. A., S. N. Tabrizi, C. K. Fairley, and S. Garland. 2004. Validation of Roche COBAS Amplicor assay for detection of Chlamydia trachomatis in rectal and pharyngeal specimens by an omp1 PCR assay. J. Clin. Microbiol.42:239-241.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Morré, S. A., J. M. Ossewaarde, J. Lan, G. J. van Doornum, J. M. Walboomers, D. M. MacLaren, C. J. L. M. Meijer, and A. J. C. van den Brule. 1998. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J. Clin. Microbiol.36:345-351.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Morré, S. A., J. Spaargaren, J. S. A. Fennema, H. J. C. de Vries, R. A. Coutinho, and A. S. Peña. 2005. Real-time polymerase chain reaction to diagnose lymphogranuloma venereum. Emerg. Infect. Dis.11:1311-1312. [Online.] http://www.cdc.gov/ncidod/EID/vol11no08/05-0535.htm .
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Perine, P. L., and W. E. Stamm. 1999. Lymphogranuloma venereum, p. 423-432. In K. K. Holmes, P. A. Mårdh, P. F. Sparling, et al. (ed.), Sexually transmitted diseases. McGraw-Hill, New York, N.Y.
  5. 5.↵
    Spaargaren, J., J. S. A. Fennema, S. A. Morré, H. J. C. de Vries, and, R. A. Coutinho. 2005. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerg. Infect. Dis.11:1090-1092.
    OpenUrlPubMedWeb of Science
  6. 6.↵
    Sturm, P. D., P. Moodley, K. Govender, L. Bohlken, T. Vanmali, and A. W. Sturm. 2005. Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease. J. Clin. Microbiol.43:2973-2975.
    OpenUrlAbstract/FREE Full Text

Authors' Reply

We agree that the absence of a restriction step in a diagnostic nucleic acid amplification test (NAAT) makes the test easier to perform. It would be interesting to compare test performance parameters of the CrP-PCR-D test with the test described by Morre et al.

Regarding the textbook description of clinical presentation of LGV, we do not dispute whether the clinical entity of inconspicuous ulcers followed by inguinal lymphadenopathy exists or not. We do see such cases in South Africa regularly. What is missing in the textbooks is that patients also present with larger, painful lesions before the lymphadenopathy develops. Such ulcers are not inconspicuous at all. As such ulcerscannot be differentiated clinically from genital ulcers with other etiology without the help of a diagnostic NAAT, these have so far been misdiagnosed. We recently completed a prospective study to describe in detail the clinical presentation of this early stage of LGV and confirmed the observations as published in our paper.

PreviousNext
Back to top
Download PDF
Citation Tools
Molecular Diagnosis of Lymphogranuloma Venereum: PCR-Based Restriction Fragment Length Polymorphism and Real-Time PCR
Servaas A. Morré, Joke Spaargaren, Johan S. A. Fennema, Henry J. C. de Vries
Journal of Clinical Microbiology Oct 2005, 43 (10) 5412-5413; DOI: 10.1128/JCM.43.10.5412-5413.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Diagnosis of Lymphogranuloma Venereum: PCR-Based Restriction Fragment Length Polymorphism and Real-Time PCR
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Molecular Diagnosis of Lymphogranuloma Venereum: PCR-Based Restriction Fragment Length Polymorphism and Real-Time PCR
Servaas A. Morré, Joke Spaargaren, Johan S. A. Fennema, Henry J. C. de Vries
Journal of Clinical Microbiology Oct 2005, 43 (10) 5412-5413; DOI: 10.1128/JCM.43.10.5412-5413.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

Chlamydia trachomatis
Genital Diseases, Male
Lymphogranuloma Venereum
polymerase chain reaction
Polymorphism, Restriction Fragment Length
Ulcer

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X